Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
Insulin resistance and β-cell failure are the major defects in type 2 diabetes mellitus. However, the molecular mechanisms linking these two defects remain unknown. Elevated levels of apolipoprotein CIII (apoCIII) are associated not only with insulin resistance but also with cardiovascular disorders...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 112; no. 20; pp. E2611 - E2619 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
19.05.2015
National Acad Sciences |
Series | PNAS Plus |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Insulin resistance and β-cell failure are the major defects in type 2 diabetes mellitus. However, the molecular mechanisms linking these two defects remain unknown. Elevated levels of apolipoprotein CIII (apoCIII) are associated not only with insulin resistance but also with cardiovascular disorders and inflammation. We now demonstrate that local apoCIII production is connected to pancreatic islet insulin resistance and β-cell failure. An increase in islet apoCIII causes promotion of a local inflammatory milieu, increased mitochondrial metabolism, deranged regulation of β-cell cytoplasmic free Ca ²⁺ concentration ([Ca ²⁺] ᵢ) and apoptosis. Decreasing apoCIII in vivo results in improved glucose tolerance, and pancreatic apoCIII knockout islets transplanted into diabetic mice, with high systemic levels of the apolipoprotein, demonstrate a normal [Ca ²⁺] ᵢ response pattern and no hallmarks of inflammation. Hence, under conditions of islet insulin resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of β-cell function and may thus constitute a novel target for the treatment of type 2 diabetes mellitus.
Significance Insulin resistance and β-cell failure are the major defects in type 2 diabetes. We now demonstrate that local insulin resistance-induced increase in apolipoprotein CIII (apoCIII) within pancreatic islets causes promotion of an intraislet inflammatory milieu, increased mitochondrial metabolism, deranged regulation of β-cell cytoplasmic free Ca ²⁺ concentration ([Ca ²⁺] ᵢ), and apoptosis. Decreasing apoCIII in vivo in animals with insulin resistance improves glucose tolerance, and apoCIII knockout islets transplanted into diabetic mice, with high systemic levels of apoCIII, demonstrate a normal [Ca ²⁺] ᵢ response pattern and no hallmarks of inflammation. Hence, under conditions of islet insulin resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of β-cell function and may thus constitute a novel target for the treatment of type 2 diabetes. |
---|---|
Bibliography: | http://dx.doi.org/10.1073/pnas.1423849112 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved April 14, 2015 (received for review December 12, 2014) Author contributions: K.Å., Y.A., I.B.L., B.L., P.-O.B., and L.J.-B. designed research; K.Å., Y.A., I.B.L., B.L., T.M., M.P., A.D., E.D., M.K., E.I., V.S.Y.T., E.R., S.J., and L.S. performed research; M.G., R.M.C., and S.K.N. contributed new reagents/analytic tools; K.Å., Y.A., I.B.L., B.L., T.M., M.P., E.D., M.K., E.I., M.H.A., P.-O.B., and L.J.-B. analyzed data; and Y.A., I.B.L., P.-O.B., and L.J.-B. wrote the paper. 1K.Å. and Y.A. contributed equally to this work. |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1423849112 |